Interestingly, in four different glioma cell lines (A172, U87-MG, M059K,M059J) rosiglitazone led to inhibition of proliferation and induction ofapoptosis in a PPARγ-dependentway since there the antagonist GW9662 partially reverted this effect [46]. The gene discussed is PPARG; the disease is central nervous system cancer.